The company is worried mislabeling could lead to unintentionally taking higher doses and adverse side effects.
Mumbai: Marksans Pharma Limited has announced the final approval of its Abbreviated New Drug Application (ANDA) for Loratadine Tablets USP 10 mg from the USFDA. Loratadine Tablets USP 10 mg are ...
USFDA approved the pharmaceutical company's Abbreviated New Drug Application (ANDA) for Loratadine Tablets USP 10 mg.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback